ARKG - ARK Genomic Revolution ETF
The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity securities issued by both domestic and international companies. These companies are strategically chosen from various sectors based on their direct connection to the fund's core investment principle: the groundbreaking genomics revolution.
As of Jun 30, 2026: spot at $42.09, ATM IV 55.5%, max pain $35.00, net GEX $3.3M.
- Sector
- Financial Services
- Industry
- Asset Management
- Market Cap
- $1.41B
- Beta
- 2.49
- 52-Week Range
- 22.73-42.149
- IPO Date
- Oct 31, 2014
- Exchange
- CBOE
What ARKG Looks Like to Options Traders Today
IV rank of 53.1% sits near the 1-year median, where strategy choice depends on directional conviction and the event calendar rather than vol regime alone; positive net gamma exposure ($3.3M) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.003) is roughly flat across the wings.
What This Page Covers
The ARKG overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure.
Frequently asked ARKG overview questions
- What is ARKG?
- ARKG is the ticker symbol for ARK Genomic Revolution ETF, an listed exchange-traded fund. The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity securities issued by both domestic and international companies. Listed on CBOE. ARKG is the ETF ticker shown on this page; ETF traders use the fund for diversified exposure to its underlying basket, for sector and factor rotation, and for hedging or replication strategies via the listed options chain.
- What does the ARKG options snapshot look like today?
- As of Jun 30, 2026, the ARKG options snapshot shows spot at $42.09, ATM IV 55.5%, IV rank 53.1%, max pain $35.00, net GEX $3.3M, expected move 15.91%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are ARKG's key statistics?
- ARK Genomic Revolution ETF (ARKG) carries a market capitalization of $1.41B, 52-week range of 22.73-42.149. Full holdings disclosure, expense ratio, and tracking-error history live on the per-ticker fundamentals page or the sponsor's site; daily NAV and premium/discount-to-NAV are accessible from the same view. These structural inputs frame how the ETF options market prices implied volatility relative to its constituents.
- What sector or industry does ARKG belong to?
- ARK Genomic Revolution ETF operates in the Financial Services sector, in the Asset Management industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare ARKG's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the ARKG data on this page?
- The options snapshot above is dated Jun 30, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Fund-level fields (sponsor, expense ratio, holdings concentration where available) refresh from the vendor feed nightly. ETF-specific filings (N-CSR, N-PX, N-CEN) update on the SEC EDGAR cadence. FINRA microstructure data refreshes on the source's cadence; for ETFs the off-exchange volume signal is dominated by authorized-participant creation and redemption rather than directional flow.